Abstract
It is difficult to regenerate mammalian retinal cells once the adult retina is damaged, and current clinical approaches to retinal damages are very limited. The introduction of the retinal organoid technique empowers researchers to study the molecular mechanisms controlling retinal development, explore the pathogenesis of retinal diseases, develop novel treatment options, and pursue cell/tissue transplantation under a certain genetic background. Here, we revisit the historical background of retinal organoid technology, categorize current methods of organoid induction, and outline the obstacles and potential solutions to next-generation retinal organoids. Meanwhile, we recapitulate recent research progress in cell/tissue transplantation to treat retinal diseases, and discuss the pros and cons of transplanting single-cell suspension versus retinal organoid sheet for cell therapies.
Funding Information
  • National Natural Science Foundation of China (31871497, 81670862, 81970794)
  • National Key Research and Development Program of China (2017YFA0104100)
  • Science and Technology Planning Projects of Guangzhou City (201904010358, 201904020036)
  • Fundamental Research Funds of the State Key Laboratory of Ophthalmology, Sun Yat-sen University (2021)

This publication has 142 references indexed in Scilit: